Variant NM_000492.4:c.3181G>C


Variant details:
Name NM_000492.4:c.3181G>C
Protein name NP_000483.3:p.(Gly1061Arg)
Genomic name (hg19) chr7:g.117251676G>C    UCSC    
#Exon/intron exon 20
Legacy Name G1061R
Class disease-causing
Subclass CF-causing
WT sequence CACTCATCTTGTTACAAGCTTAAAA G GACTATGGACACTTCGTGCCTTCGG
Mutant sequence CACTCATCTTGTTACAAGCTTAAAA C GACTATGGACACTTCGTGCCTTCGG

Other databases:
dbSNP
rs142394380



Pathogenicity predictors:




Modulator FDA approval EMA approval in vitro / ex vivo data clinical data
IVAnononono
TEZ-IVAnononono
ELX-TEZ-IVA yesnoyesno


clinical and functional data are provided by Vertex


No patient found in CFTR-NGS catalogue


5 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 5
CF 4
Pending 1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
CF 2497heterozygoteCF-causing- Undef
CF 4633heterozygoteCF-causing- Undef
CF 3410heterozygoteCF-causing - Trans
CF 3737heterozygoteCF-causing- Undef
Pending 5568heterozygoteCF-causing - Trans


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare